All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • HP568Phase 21 trial

    Hinova Pharmaceuticals Inc. · Breast Cancer

  • HR19042Phase 21 trial

    Jiangsu HengRui Medicine Co., Ltd. · Autoimmune Hepatitis

  • HRS-1301Phase 21 trial

    Shandong Suncadia Medicine Co., Ltd. · Hyperlipidemia

  • HRS-1738Phase 21 trial

    Jiangsu HengRui Medicine Co., Ltd. · PET Imaging in Patients With Prostate Cancer

  • HRS-3095Phase 21 trial

    Chengdu Suncadia Medicine Co., Ltd. · Chronic Spontaneous Urticaria

  • HRS-4029Phase 21 trial

    Beijing Suncadia Pharmaceuticals Co., Ltd · Acute Ischemic Stroke

  • HRS-5632Phase 21 trial

    Fujian Shengdi Pharmaceutical Co., Ltd. · Lipoprotein Disorder

  • HRS-6213Phase 21 trial

    Jiangsu HengRui Medicine Co., Ltd. · Patients With Solid Tumors

  • HRS-6719Phase 21 trial

    Shandong Suncadia Medicine Co., Ltd. · Advanced/Metastatic Solid Tumors

  • HRS-6768Phase 21 trial

    Jiangsu HengRui Medicine Co., Ltd. · Advanced Solid Tumors

  • HRS-7085Phase 21 trial

    Shandong Suncadia Medicine Co., Ltd. · Adult Patients With Moderately to Severely Active Ulcerative Colitis

  • HRS-717Phase 21 trial

    Jiangsu HengRui Medicine Co., Ltd. · Pancreatic Cancer

  • HRS-7172Phase 21 trial

    Jiangsu HengRui Medicine Co., Ltd. · Pancreatic Cancer

  • HRS-7450Phase 21 trial

    Fujian Shengdi Pharmaceutical Co., Ltd. · Acute Ischemic Stroke

  • HRS-8364Phase 21 trial

    Jiangsu HengRui Medicine Co., Ltd. · Solid Tumor

  • HRS-9308Phase 21 trial

    Chengdu Suncadia Medicine Co., Ltd. · Solid Tumor

  • HRS-9563Phase 21 trial

    Fujian Shengdi Pharmaceutical Co., Ltd. · Mild to Moderate Hypertension

  • HRS-9821Phase 21 trial

    Guangdong Hengrui Pharmaceutical Co., Ltd · COPD

  • HRS5580Phase 21 trial

    Fujian Shengdi Pharmaceutical Co., Ltd. · Prevention of Postoperative Nausea and Vomiting

  • HRS9432Phase 21 trial

    Fujian Shengdi Pharmaceutical Co., Ltd. · Patients With Candidemia and/or Invasive Candidiasis

  • HRS9950Phase 21 trial

    Chengdu Suncadia Medicine Co., Ltd. · Chronic Hepatitis B

  • HRX215Phase 21 trial

    HepaRegeniX GmbH · Liver Resection, Colorectal Carcinoma Liver Metastases

  • HS-10365Phase 21 trial

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · Nonsmall Cell Lung Cancer

  • HS-10374Phase 21 trial

    Hansoh BioMedical R&D Company · Psoriasis

  • HS-10390Phase 21 trial

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · Chronic Kidney Disease

  • HS-10516Phase 21 trial

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · Advanced Clear Cell Renal Cell Carcinoma

  • HS-10561Phase 21 trial

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · Chronic Spontaneous Urticaria

  • HS-10566Phase 21 trial

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · High-risk Non-muscle-invasive Bladder Cancer

  • HS-20105Phase 21 trial

    Hansoh BioMedical R&D Company · Advanced Solid Tumor

  • HS-20110Phase 21 trial

    Hansoh BioMedical R&D Company · CRC

  • HS-20118Phase 21 trial

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · Moderate to Severe Plaque Psoriasis

  • HSK39775Phase 21 trial

    Xizang Haisco Pharmaceutical Co., Ltd · Advanced Solid Tumors

  • HSK42360-NaPhase 21 trial

    Haisco Pharmaceutical Group Co., Ltd. · Metastatic Colorectal Cancer (CRC)

  • HSK50042Phase 21 trial

    Haisco Pharmaceutical Group Co., Ltd. · Idiopathic Pulmonary Fibrosis (IPF)

  • HST-1011Phase 21 trial

    HotSpot Therapeutics, Inc · Solid Tumor, Adult, Relapsed Cancer, Refractory Cancer

  • HT-4253Phase 21 trial

    Halia Therapeutics, Inc. · Alzheimers Disease

  • HTMC0658YD0293Phase 21 trial

    Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. · Chronic Sinusitis Without Nasal Polyps

  • HuL001Phase 21 trial

    HuniLife Biotechnology, Inc. · Multiple Myeloma Refractory

  • HW091077Phase 21 trial

    Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. · Refractory Chronic Cough

  • HW201877Phase 21 trial

    Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. · Inflammatory Bowel Disease (IBD)

  • HW211026Phase 21 trial

    Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. · Actinic Keratosis

  • HX009Phase 21 trial

    Hangzhou Hanx Biopharmaceuticals, Ltd. · Biliary Tract Cancer, Melanoma

  • HX044Phase 21 trial

    Hanx Biopharmaceuticals (Wuhan) Co., Ltd. · Advanced Solid Tumor Malignancies

  • HX111Phase 21 trial

    Hanx Biopharmaceuticals (Wuhan) Co., Ltd. · Solid Tumor and Lymphoma

  • HX301Phase 21 trial

    Hangzhou Hanx Biopharmaceuticals, Ltd. · Glioma

  • HX9428Phase 21 trial

    Fujian Haixi Pharmaceuticals Co., Ltd. · Wet Age-related Macular Degeneration (AMD)

  • HXN6005Phase 21 trial

    Helixon Biotechnology (Suzhou) Co., Ltd · Health Adult Subjects, Atopic Dermatitis (AD)

  • HY-0102Phase 21 trial

    Shanghai YingLi Pharmaceutical Co. Ltd. · Metastatic Pancreatic Cancer

  • HY05350Phase 21 trial

    Sichuan Huiyu Pharmaceutical Co., Ltd · Advanced Solid Tumor

  • IAM1363Phase 21 trial

    Iambic Therapeutics, Inc · HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer

NewerPage 56 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.